Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-26

Clinical Trial Update: Rosuvastatin and Renal Endothelial Function [Phase 2]

View source ↗

Summary

Phase 2 trial update examining the effect of rosuvastatin on renal endothelial function in individuals with hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rosuvastatin (rosuvastatin)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED